Intellia Therapeutics, Inc.
NTLA- Exchange
- Nasdaq
- Industry
- In Vitro & In Vivo Diagnostic Substances
- SEC CIK
- 0001652130
In the last 90 days, Intellia Therapeutics, Inc. insiders filed 0 open-market purchases and 4 sales; 329 institutions reported holding it in 13F filings for Q2 2026, worth $2.43B in total; ARK Invest is the only superinvestor holding it.
13F holders, Q2 2024
Institutional positions in Intellia Therapeutics, Inc. as of Jun 30, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 291
- +11 vs. Q1 2024
- Shares held
- 90.1M
- −982.8K (−1.1%) vs. Q1 2024
- Total value
- $2.02B
- −$491.0M (−19.6%) vs. Q1 2024
- New holders
- 48
- 114 more added
- Sold out
- 37
- 88 more reduced
4 institutions that held it in Q1 2024 haven't filed for Q2 2024 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q1 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting NTLA on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 329 | $2.43B |
| Q1 2026 | 306 | $1.41B |
| Q4 2025 | 295 | $938.9M |
| Q3 2025 | 284 | $1.80B |
| Q2 2025 | 283 | $933.8M |
| Q1 2025 | 296 | $720.3M |
| Q4 2024 | 295 | $1.16B |
| Q3 2024 | 284 | $1.92B |
| Q2 2024 | 291 | $2.02B |
| Q1 2024 | 284 | $2.51B |
| Q4 2023 | 293 | $2.60B |
| Q3 2023 | 286 | $2.53B |
| Q2 2023 | 292 | $3.19B |
| Q1 2023 | 291 | $2.93B |
| Q4 2022 | 304 | $2.72B |
| Q3 2022 | 321 | $3.81B |
| Q2 2022 | 301 | $3.44B |
| Q1 2022 | 348 | $4.71B |
| Q4 2021 | 372 | $7.60B |
| Q3 2021 | 366 | $8.34B |
| Q2 2021 | 337 | $10.0B |
| Q1 2021 | 261 | $5.07B |
Institutions, Q2 2024
Shares, value and share of portfolio for each institution holding Intellia Therapeutics, Inc.; share changes are against Q1 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Man Group plc | 0 | $0 | 0.00% | −47,986−100.0% | Sold out |
| Qube Research & Technologies Ltd | 0 | $0 | 0.00% | −44,588−100.0% | Sold out |
| American International Group, Inc. | 0 | $0 | 0.00% | −44,180−100.0% | Sold out |
| SageView Advisory Group, LLC | 0 | $0 | 0.00% | −19,345−100.0% | Sold out |
| TD Asset Management Inc | 0 | $0 | 0.00% | −30,692−100.0% | Sold out |
| Virtu Financial LLC | 0 | $0 | 0.00% | −29,144−100.0% | Sold out |
| Cubist Systematic Strategies, LLC | 0 | $0 | 0.00% | −23,159−100.0% | Sold out |
| Blair William & Co | 0 | $0 | 0.00% | −10,307−100.0% | Sold out |
| JustInvest LLC | 0 | $0 | 0.00% | −8,944−100.0% | Sold out |
| Privium Fund Management B.V. | 0 | $0 | 0.00% | −8,905−100.0% | Sold out |
| Sectoral Asset Management Inc | 0 | $0 | 0.00% | −8,800−100.0% | Sold out |
| Azzad Asset Management Inc | 0 | $0 | 0.00% | −8,496−100.0% | Sold out |
| Steel Peak Wealth Management LLC | 0 | $0 | 0.00% | −8,309−100.0% | Sold out |
| Cyndeo Wealth Partners, LLC | 0 | $0 | 0.00% | −8,224−100.0% | Sold out |
| AXA S.A. | 0 | $0 | 0.00% | −8,223−100.0% | Sold out |
| Green Alpha Advisors, LLC | 0 | $0 | 0.00% | −7,964−100.0% | Sold out |
| Quadcap Wealth Management, LLC | 0 | $0 | 0.00% | −7,916−100.0% | Sold out |
| Nomura Holdings Inc | 0 | $0 | 0.00% | −7,740−100.0% | Sold out |
| Fort Sheridan Advisors LLC | 0 | $0 | 0.00% | −7,478−100.0% | Sold out |
| Metropolitan Life Insurance Co | 0 | $0 | 0.00% | −4,830−100.0% | Sold out |
| Point72 Asia (Singapore) Pte. Ltd. | 0 | $0 | 0.00% | −4,739−100.0% | Sold out |
| Natixis | 0 | $0 | 0.00% | −2,045−100.0% | Sold out |
| Bank Julius Baer & Co. Ltd, Zurich | 0 | $0 | 0.00% | −1,897−100.0% | Sold out |
| Quarry LP | 0 | $0 | 0.00% | −1,800−100.0% | Sold out |
| nVerses Capital, LLC | 0 | $0 | 0.00% | −1,100−100.0% | Sold out |
| Fifth Third Bancorp | 0 | $0 | 0.00% | −150−100.0% | Sold out |
| GWM Advisors LLC | 0 | $0 | 0.00% | −40−100.0% | Sold out |
| Nelson, Van Denburg & Campbell Wealth Management Group, LLC | 0 | $0 | 0.00% | −17−100.0% | Sold out |
| Credit Suisse AG | – | – | – | – | Not filed |
| Merlin Capital LLC | – | – | – | – | Not filed |
| Shell Asset Management Co | – | – | – | – | Not filed |
| Cambridge Trust Co | – | – | – | – | Not filed |